PharmaCielo Ltd. (TSXV:PCLO)
0.0700
-0.0100 (-12.50%)
At close: Feb 9, 2026
PharmaCielo Balance Sheet
Financials in millions CAD. Fiscal year is April - March.
Millions CAD. Fiscal year is Apr - Mar.
Fiscal Year | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
Period Ending | Sep '25 Sep 30, 2025 | Mar '25 Mar 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
Cash & Equivalents | 0.26 | 0.05 | 0.15 | 0.06 | 0.17 | 5.34 |
Short-Term Investments | - | - | - | - | 0.15 | 0.29 |
Cash & Short-Term Investments | 0.26 | 0.05 | 0.15 | 0.06 | 0.33 | 5.63 |
Cash Growth | 913.59% | -63.42% | 137.92% | -80.93% | -94.21% | -41.42% |
Accounts Receivable | 0.46 | 0.47 | 0.34 | 0.23 | 0.61 | 0.28 |
Other Receivables | 0.33 | 0.49 | 0.25 | 0.53 | 0.79 | 0.29 |
Receivables | 0.79 | 0.96 | 0.6 | 0.76 | 1.41 | 0.57 |
Inventory | 1.41 | 1.37 | 1.5 | 2.31 | 2.13 | 2.28 |
Prepaid Expenses | 1.09 | 0.03 | 0.18 | 0.19 | 0.15 | 0.72 |
Total Current Assets | 3.55 | 2.41 | 2.44 | 3.33 | 4.02 | 9.2 |
Property, Plant & Equipment | 5.09 | 16.12 | 15.73 | 18.71 | 20.62 | 26.12 |
Long-Term Investments | - | - | 0.23 | 0.21 | 0.2 | 0.64 |
Long-Term Accounts Receivable | - | - | - | 0.04 | 0.27 | - |
Total Assets | 8.64 | 18.53 | 18.39 | 22.29 | 25.12 | 35.96 |
Accounts Payable | 5.61 | 5.76 | 5.24 | 5.63 | 6.11 | 7.73 |
Accrued Expenses | 0.03 | 0.03 | 0.03 | 0.03 | 0.03 | 0.11 |
Current Portion of Long-Term Debt | 17.82 | 17.61 | 15.85 | 15.71 | 0.55 | 0.08 |
Current Portion of Leases | - | - | - | 0.04 | 0.27 | 0.15 |
Other Current Liabilities | 0.12 | - | 0.12 | - | - | - |
Total Current Liabilities | 23.57 | 23.4 | 21.23 | 21.42 | 6.95 | 8.07 |
Long-Term Debt | - | 4.62 | 4.68 | 2.55 | 11.73 | 7.14 |
Long-Term Leases | - | - | - | - | 0.04 | 1.06 |
Long-Term Unearned Revenue | - | - | - | - | - | 0.36 |
Total Liabilities | 23.57 | 28.02 | 25.91 | 23.97 | 18.72 | 16.63 |
Common Stock | 168.15 | 168.15 | 167.01 | 165.98 | 161.71 | 156.34 |
Retained Earnings | -212.77 | -210.08 | -207.85 | -198.71 | -182.41 | -167.9 |
Comprehensive Income & Other | 29.68 | 32.44 | 33.32 | 31.05 | 27.09 | 30.89 |
Shareholders' Equity | -14.94 | -9.49 | -7.52 | -1.68 | 6.39 | 19.33 |
Total Liabilities & Equity | 8.64 | 18.53 | 18.39 | 22.29 | 25.12 | 35.96 |
Total Debt | 17.82 | 22.23 | 20.52 | 18.31 | 12.59 | 8.43 |
Net Cash (Debt) | -17.56 | -22.18 | -20.38 | -18.25 | -12.26 | -2.8 |
Net Cash Per Share | -0.10 | -0.13 | -0.12 | -0.11 | -0.08 | -0.02 |
Filing Date Shares Outstanding | 187.98 | 187.98 | 175.72 | 169.14 | 155.24 | 150.52 |
Total Common Shares Outstanding | 187.98 | 187.98 | 175.72 | 169.14 | 154.96 | 149.27 |
Working Capital | -20.03 | -20.99 | -18.8 | -18.09 | -2.94 | 1.13 |
Book Value Per Share | -0.08 | -0.05 | -0.04 | -0.01 | 0.04 | 0.13 |
Tangible Book Value | -14.94 | -9.49 | -7.52 | -1.68 | 6.39 | 19.33 |
Tangible Book Value Per Share | -0.08 | -0.05 | -0.04 | -0.01 | 0.04 | 0.13 |
Land | 0.89 | 7.03 | 6.8 | 7.05 | 6.21 | 6.68 |
Buildings | 7.37 | 11.56 | 10.96 | 12.46 | 10.48 | 9.47 |
Machinery | 6.35 | 6.75 | 6.45 | 6.79 | 9.16 | 14.37 |
Construction In Progress | - | - | - | - | - | 0.01 |
Source: S&P Global Market Intelligence. Standard template. Financial Sources.